Researchers discover potential avenue to treating type 2 diabetes at early stages

August 8, 2016, Sanford-Burnham Prebys Medical Discovery Institute
Blood glucose monitoring. Credit: Wikipedia

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new potential target for drugs to prevent type 2 diabetes. A paper published today in the Journal of Clinical Investigation shows that blocking a cellular glucose sensor in muscle improves insulin responsiveness.

"Our new study shows that a protein called MondoA may serve as a key link between insulin resistance and accumulation of fat in muscle, which occurs in obesity-related ," said Daniel P. Kelly, M.D., professor and director of SBP's Center for Metabolic Origins of Disease. "This study is the first step towards testing MondoA-targeted drugs to prevent type 2 diabetes in pre-clinical studies."

About 8% of Americans have type 2 diabetes, and another 25% of the population is at risk because of obesity. Type 2 diabetes is a lifelong disease that represents an enormous public health burden, accounting for as much as 20% of all healthcare costs in the US. A significant proportion of those costs result from complications of diabetes, including damage to the kidneys, peripheral nerves, and retinas.

The precursor to type 2 diabetes is insulin resistance, in which insulin no longer causes the body's cells to take up the from a meal and use it for energy. This leads to diabetes because glucose continues to circulate in the blood, stimulating the pancreas to make more and more insulin, which eventually becomes so taxing that the insulin-producing cells die.

Kelly's team focused on skeletal muscle because it's the main insulin-responsive tissue in the body. An early marker of insulin resistance is the accumulation of fat in muscle, along with decreased import of glucose, so they examined whether these two processes are linked. To find a protein that regulates both, they screened thousands of molecules for their ability to block fat synthesis and enhance glucose uptake in muscle cells.

"Investigating the cellular effects of SBI-477, the best hit molecule from our screen, led us to MondoA," added Kelly. "Our experiments showed that this protein regulates genes involved in synthesizing fats as well as inhibiting insulin signaling."

"Until now, it wasn't clear why people who are insulin resistant accumulate fat in their muscle," he explained. "These results show that MondoA is one mechanism that ties these phenomena together, serving as a gatekeeper for fuel burning in muscle."

The researchers went on to demonstrate that SBI-477 also enhances glucose uptake in liver cells, suggesting that a MondoA blocker may have this effect on multiple tissues. Further, it mitigates insulin resistance in mice fed a high-fat diet.

"We think that MondoA normally responds to oversupply of glucose by inhibiting transport of glucose into cells and enhancing its conversion to fat, but persistent activation promotes ," Kelly said.

Kelly and his collaborators next plan to develop better molecules that inhibit MondoA.

"Directly enhancing by and other tissues is a very different strategy from those of other anti-diabetic drugs in development. Since this action would favor energy burning, it may also have beneficial effects on overall metabolism and body weight."

Explore further: Skeletal muscle TRIB3 mediates diet-induced insulin resistance

More information: Byungyong Ahn et al. MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI87382

Related Stories

Skeletal muscle TRIB3 mediates diet-induced insulin resistance

May 18, 2016
(HealthDay)—Skeletal muscle TRIB3 mediates glucose-induced insulin resistance (GIIR) in a mouse model of diabetes, according to a study published online May 10 in Diabetes.

Gastric bypass surgery improves blood sugar handling and insulin sensitivity, study finds

October 5, 2015
Roux-en-Y, the most common type of gastric bypass surgery, can lead to remission of type 2 diabetes along with weight loss. A new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology ...

Researchers identify cause of insulin resistance in type 2 diabetics

March 7, 2016
More than 29 million Americans are currently living with diabetes. The majority have type 2 diabetes, and for them insulin resistance - their body's inability to effectively process sugar - is a part of daily life. Therefore, ...

Junk food causes similar high blood sugar levels as type 2 diabetes

May 10, 2016
A junk food diet can cause as much damage to the kidney as diabetes, according to a study published in Experimental Physiology.

Study characterizes insulin secretion in response to metabolic stress

April 7, 2016
The development of type 2 diabetes is linked to persistent inflammation as a consequence of metabolic stress. Prolonged exposure to the proinflammatory molecule IL-1β is associated with reduced insulin secretion by pancreatic ...

How brown fat fuels up to combat type 2 diabetes and obesity

November 10, 2014
A newly identified signaling pathway that stimulates glucose uptake in brown fat cells might be useful for treating type 2 diabetes and obesity, according to a study in The Journal of Cell Biology.

Recommended for you

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

High blood sugar during pregnancy ups risk of mother's type 2 diabetes, child's obesity

September 11, 2018
Mothers with elevated blood glucose during pregnancy—even if not high enough to meet the traditional definition of gestational diabetes—were significantly more likely to have developed type 2 diabetes a decade after pregnancy ...

Want to avoid type 2 diabetes? Eat more whole grains

September 11, 2018
(HealthDay)—It may seem counterintuitive, but eating bread, pasta and cereal may actually help prevent type 2 diabetes, as long as those foods are made from whole grains, new research suggests.

Exercise could delay progression of type 1 diabetes when first diagnosed

September 5, 2018
The findings of a study led by the University of Birmingham suggests that exercise during the first few months of diagnosis of type 1 diabetes could delay the progression of the condition.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.